Literature DB >> 15621426

Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.

Jonathan Warawa1, Donald E Woods.   

Abstract

Burkholderia pseudomallei, the etiological agent of melioidosis, is an animal pathogen capable of inducing a highly fatal septicemia. B. pseudomallei possesses three type III secretion system (TTSS) clusters, two of which (TTSS1 and TTSS2) are homologous to the TTSS of the plant pathogen Ralstonia solanacearum, and one (TTSS3) is homologous to the Salmonella SPI-1 mammalian pathogenicity island. We have demonstrated that TTSS3 is required for the full virulence of B. pseudomallei in a hamster model of infection. We have also examined the virulence of B. pseudomallei mutants deficient in several putative TTSS3 effector molecules, and found no significant attenuation of B. pseudomallei virulence in the hamster model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15621426     DOI: 10.1016/j.femsle.2004.10.045

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  71 in total

1.  Endofungal bacterium controls its host by an hrp type III secretion system.

Authors:  Gerald Lackner; Nadine Moebius; Christian Hertweck
Journal:  ISME J       Date:  2010-08-19       Impact factor: 10.302

2.  Comparative assessment of the intracellular survival of the Burkholderia pseudomallei bopC mutant.

Authors:  Varintip Srinon; Sunsiree Muangman; Nithima Imyaem; Veerachat Muangsombut; Natalie R Lazar Adler; Edouard E Galyov; Sunee Korbsrisate
Journal:  J Microbiol       Date:  2013-08-30       Impact factor: 3.422

3.  Multinucleated giant cell formation and apoptosis in infected host cells is mediated by Burkholderia pseudomallei type III secretion protein BipB.

Authors:  Supaporn Suparak; Wannapa Kespichayawattana; Ashraful Haque; Anna Easton; Suwat Damnin; Ganjana Lertmemongkolchai; Gregory J Bancroft; Sunee Korbsrisate
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

4.  The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages.

Authors:  Wilson J Ribot; Ricky L Ulrich
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; Paul J Brett; Vinod Nair; Jonathan M Warawa; Donald E Woods; Frank C Gherardini
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

6.  Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; David DeShazer; Vinod Nair; Frank C Gherardini; Paul J Brett
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

Review 7.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

8.  The twin arginine translocation system is essential for aerobic growth and full virulence of Burkholderia thailandensis.

Authors:  Sariqa Wagley; Claudia Hemsley; Rachael Thomas; Madeleine G Moule; Muthita Vanaporn; Clio Andreae; Matthew Robinson; Stan Goldman; Brendan W Wren; Clive S Butler; Richard W Titball
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

9.  Evolutionary analysis of Burkholderia pseudomallei identifies putative novel virulence genes, including a microbial regulator of host cell autophagy.

Authors:  Arvind Pratap Singh; Shu-chin Lai; Tannistha Nandi; Hui Hoon Chua; Wen Fong Ooi; Catherine Ong; John D Boyce; Ben Adler; Rodney J Devenish; Patrick Tan
Journal:  J Bacteriol       Date:  2013-10-04       Impact factor: 3.490

10.  Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin.

Authors:  Zhiyong Ye; Cheryl Mei Ling Lee; Guang Wen Sun; Yunn-Hwen Gan
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.